Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma
AuthorsBates, Richard C.
Bellovin, David I.
Mercurio, Arthur M.
UMass Chan AffiliationsDepartment of Cancer Biology
Gene Expression Regulation, Neoplastic
Integrin beta Chains
Transforming Growth Factor beta
Tumor Markers, Biological
MetadataShow full item record
AbstractWe used a spheroid model of colon carcinoma to analyze integrin dynamics as a function of the epithelial-mesenchymal transition (EMT), a process that provides a paradigm for understanding how carcinoma cells acquire a more aggressive phenotype. This EMT involves transcriptional activation of the beta6 integrin subunit and a consequent induction of alphavbeta6 expression. This integrin enhances the tumorigenic properties of colon carcinoma, including activation of autocrine TGF-beta and migration on interstitial fibronectin. Importantly, this study validates the clinical relevance of the EMT. Kaplan-Meier analysis of beta6 expression in 488 colorectal carcinomas revealed a striking reduction in median survival time of patients with high beta6 expression. Elevated receptor expression did not simply reflect increasing tumor stage, since log-rank analysis showed a more significant impact on the survival of patients with early-stage, as opposed to late-stage, disease. Cox regression analysis confirmed that this integrin is an independent variable for these tumors. These findings define the alphavbeta6 integrin as an important risk factor for early-stage disease and a novel therapeutic candidate for colorectal cancer.
SourceJ Clin Invest. 2005 Feb;115(2):339-47. Link to article on publisher's site
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/26265
Related ResourcesLink to Article in PubMed